The affinity of a flexible ligand that adopts a specific conformation
when bound to its receptor should be increased with the appropriate us
e of conformational restraints. By determining the structure of protei
n-ligand complexes, such restraints can in principle be designed into
the bound ligand in a rational way. A tricyclic variant (TCsA) of the
immunosuppressant cyclosporin A (CsA), which inhibits the proliferatio
n of T lymphocytes by forming a cyclophilin-CsA-calcineurin complex, w
as designed with the known three-dimensional structure of a cyclophili
n-CsA complex. The conformational restraints in TCsA appear to be resp
onsible for its greater affinity for cyclophilin and calcineurin relat
ive to CsA.